Journal Article

Effects of HIV infection in plasma free fatty acid profiles among people with non-alcoholic fatty liver disease J

Talavera-Rodríguez, Alba, Díaz-Álvarez, Jorge, Martínez-Sanz, Javier, Serrano-Villar, Sergio, Rosas, Marta, Moreno, Santiago, Sánchez-Conde, Matilde, Calvo, María Visitación, Montes, María Luisa, Martín-Mateos, Rosa, Fontecha, Javier, Burgos-Santamaría, Diego

2022

Overview

Despite its high prevalence, the mechanisms underlying non-alcoholic fatty liver disease (NAFLD) in people living with HIV (PLWH) are still unclear. In this prospective cohort study, we aim to evaluate differences in plasma fatty acid profiles between HIV-infected and HIV-uninfected participants with NAFLD. We included participants diagnosed with NAFLD, both HIV-infected and HIV-uninfected. Fatty acid methyl esters were measured from plasma samples. Ratios ([product]/[substrate]) were used to estimate desaturases and elongases activity. We used linear regression for adjusted analyses. We included 31 PLWH and 22 HIV-uninfected controls. We did not find differences in the sum of different types of FA or in FA with a greater presence of plasma. However, there were significant differences in the distribution of some FA, with higher concentrations of ALA, trans-palmitoleic, and behenic acids, and a lower concentration of lignoceric acid in PLWH. PLWH had lower C24:0/C22:0 and C16:0/C14:0 ratios, which estimates the activity of elongases ELOVL1 and ELOVL6. Both groups had similar fatty acid distribution, despite differences in traditional risk factors. PLWH had a lower proportion of specific ratios that estimate ELOVL1 and ELOVL6 activity, which had been previously described for other inflammatory conditions, such as psoriasis.

• Publisher: MDPI AG,MDPI
• Subject: Alcohol / Clinical medicine / Drug therapy / Enzymes / Fatty acids / Fatty liver / HIV / Human immunodeficiency virus / Infections / Inflammation / Lipids / Liver diseases / Metabolic syndrome / Plasma / Population / Ultrasonic imaging